Skip to content
December 20, 2019

Role of PRAME in Epigenetic Reprogramming and Chro...

UM has a propensity to undergo early micrometastasis prior to treatment of the primary tumor, with later emergence of overt metastatic disease. Unfortunately, the...

2 Minute Read
December 20, 2019

Cellular and Genomic Landscape of Uveal Melanoma a...

Uveal melanoma (UM) is a highly aggressive eye cancer that leads to metastatic death in up to half of patients, with no measurable improvement in survival over the past hal...

2 Minute Read
December 20, 2019

The Development and Characterization of Cellular M...

Melanoma is the most aggressive form of skin cancer. Although progress has been made for advanced melanoma patients with 13 new FDA-approved therapies since 2011, resistanc...

3 Minute Read
December 20, 2018

A Novel Peripheral Blood Biomarker for Early Diagn...

Uveal melanoma is an aggressive cancer of the eye. There is no cure for metastatic disease, and therefore it is always fatal. Predictive tests can identify patients with ag...

3 Minute Read
December 20, 2018

Innovative Approaches for GNAQ/11 Mutant Character...

A type of cancer found in the colored part the eye is called uveal melanoma. This particular type of cancer can often be treated successfully with surgery and radiation. Ho...

1 Minute Read
December 20, 2017

Targeting genomic mechanisms of resistance to immu...

Immunotherapies, such as CTLA-4 or PD-1 inhibitors, have revolutionized the treatment of metastatic melanoma patients. However, a key challenge to optimize the opportunity ...

2 Minute Read
December 20, 2017

The genetic evolution of uveal melanoma

Uveal melanoma is a type of melanoma that occurs in the eye as opposed to the most common presentations of melanoma, which occur on the skin. A diagnosis of uveal ...

2 Minute Read
January 6, 2016

Epigenetic effectors of tumor response to immune c...

Description: Treatment of advanced melanoma with immunotherapy agents shows striking responses in some patients, however overall responses are low. In addition, a significa...

1 Minute Read
January 6, 2016

Mechanism of metastasis in a less common molecular...

Description: The major cause of death in uveal melanoma patients is the spread or metastasis of the cancer to other vital organs such as the liver. Although most ...

3 Minute Read
January 6, 2014

The role of BAP1 mutations in establishing a pro-m...

Medical Student Award – Matthew Field

1 Minute Read
January 6, 2014

Fast cycling Gaq Ga11

CURE OM funded award Established Investigator — CURE OM – John Sondek

1 Minute Read
January 6, 2013

Overcoming resistance to MEK inhibition in advance...

CURE OM funded Career Development Award – CURE OM – Dr. Richard Carvajal

1 Minute Read

Dec 02, 2025 ET

Ask The Expert: LAG-3 Inhibitors: Exploring a New Path in Melanoma Treatment

Dec 06, 2025 ET

Tampa Bay Miles for Melanoma 5K

Dec 13, 2025 ET

Fort Myers Miles for Melanoma 5K

Dec 13, 2025 CT

What’s New in Melanoma Management 2025: An Educational Symposium for Patients and Caregivers

Feb 08, 2026 ET

Miami Miles for Melanoma 5K

Feb 22, 2026 ET

Orange County Miles for Melanoma 5K

Mar 01, 2026 ET - Mar 03, 2026

2026 Advocacy Days

Explore Events